Inflammatory disease therapies do not increase shingles risk

Use of certain therapies for inflammatory diseases does not appear to increase risk of shingles – Although patients with rheumatoid arthritis (RA) have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens.

Anti aging drug may be available within five years

Anti-aging drug breakthrough — potential to prevent age-related diseases and extend lifespans – Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The study finally proves that a single anti-ageing enzyme in the body can be targeted, with the potential to prevent age-related diseases and extend lifespans.

Vigorous physical activity reduced psoriasis in women

Vigorous physical activity associated with reduced risk of psoriasis – A study of U.S. women suggests that vigorous physical activity may be associated with a reduced risk of psoriasis. Psoriasis is an immunologic disorder characterized by systemic inflammation and scaling of the skin.

Meditation may help brain to recover from diseases

Tuning out: How brains benefit from meditation — Meditation may help brain to recover from diseases – Brain imaging study reveals that experienced meditators seem to be able switch off areas of the brain associated with daydreaming as well as psychiatric disorders such as autism and schizophrenia.

Remicade infliximab approved to treat ulcerative colitis in children

FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

Rheumatoid arthritis and psoriasis medications lowers diabetes risk

Certain drugs lower risk of diabetes for patients with rheumatoid arthritis or psoriasis – Certain rheumatoid arthritis and psoriasis medications are associated with reduced diabetes risk, revealed by researchers. 2 disease-modifying antirheumatic drugs, TNF inhibitors and hydroxychloroquine, are associated with a reduced risk for the development of diabetes in psoriasis and rheumatoid arthritis patients

Metabolic syndrome common in psoriasis patients

Features of the metabolic syndrome common in persons with psoriasis – Individuals with psoriasis have a high prevalence of the metabolic syndrome, according to a report that will appear in the April_2011 print issue of Archives of Dermatology.

Women who drink beer may develop psoriasis

Women who drink beer more likely to develop psoriasis – Regular beer – but not light beer or other types of alcohol – appears to be associated with an increased risk of developing psoriasis, revealed by researchers.

TNF blockers will have boxed warning cancer risk

FDA: Cancer Warnings Required for TNF Blockers – The U.S. Food and Drug Administration is requiring stronger warnings in the prescribing information for a class of drugs known as TNF blockers or TNF inhibitors.

Psoriasis linked to increased heart disease risk

Psoriasis associated with cardiovascular disease and increased mortality – Psoriasis skin disease is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death, revealed by researchers.